Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.

Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.

Using a [3H]-lysergic acid diethylamide [( 3H]-LSD) binding technique, platelet 5-hydroxytryptamine (5-HT) receptor number and affinity were compared in schizophrenics treated with depot thioxanthenes and phenothiazines and controls. There was an approximately 30% increase in platelet receptor numbe...

Full description

Bibliographic Details
Main Authors:	Schächter, M, Geaney, D, Grahame-Smith, D, Cowen, P, Elliott, J
Format:	Journal article
Language:	English
Published:	1985

Similar Items

PLATELET (H-3)-LSD BINDING IN PATIENTS ON CHRONIC PHENOTHIAZINE AND THIOXANTHENE THERAPY
by: Schachter, M, et al.
Published: (1984)

Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors.
by: Cowen, P, et al.
Published: (1986)

The effects of chronic neuroleptic treatment on neurotensin-like immunoreactivity in the rat central nervous system.
by: Goedert, M, et al.
Published: (1985)

Changes in platelet alpha 2-adrenoceptor binding post partum: possible relation to maternity blues.
by: Metz, A, et al.
Published: (1983)

Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline
by: Braddock, L, et al.
Published: (1984)

Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline.
by: Braddock, L, et al.
Published: (1984)

Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
by: Cowen, P, et al.
Published: (1987)

Binding of yohimbine and imipramine to platelets in depressive illness.
by: Braddock, L, et al.
Published: (1986)

Endocrine responses to tryptophan infusion in schizophrenic patients treated with neuroleptics.
by: Kolakowska, T, et al.
Published: (1987)

Neuroleptic dosage for asian patients
by: Ismail, Rusli

Binding of tritiated yohimbine to platelets in women with maternity blues.
by: Best, N, et al.
Published: (1988)

Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding.
by: Goodwin, G, et al.
Published: (1987)

Taking LSD 1 to a new high.
by: Wysocka, J, et al.
Published: (2005)

LSD-C: linearly separable deep clusters
by: Rebuffi, SA, et al.
Published: (2021)

Reversible splenial lesion syndrome in neuroleptic malignant syndrome.
by: Al-Edrus, Sharifah Aishah, et al.
Published: (2009)

L.S.D. (Live. Shag. Die) : video drama
by: Chin, Raymond Cheng Pang, et al.
Published: (2008)

A neuroleptic-like effect of ceronapril on latent inhibition.
by: Weiner, I, et al.
Published: (1992)

Serum iron and transferrin in acute neuroleptic induced akathisia.
by: O'Loughlin, V, et al.
Published: (1991)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
by: Ford, A, et al.
Published: (1979)

Spinophilin and MAP2 gene expression in schizophrenia, mood disorder and following neuroleptic treatment in the rat
by: Law, A, et al.
Published: (2003)

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
by: Glue, P, et al.
Published: (1986)

Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen.
by: Turner, M, et al.
Published: (2001)

Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.
by: Cowen, P, et al.
Published: (1985)

Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
by: Stoessl, A, et al.
Published: (1989)

Simultaneous inhibition of LSD1 and TGFβ enables eradication of poorly immunogenic tumors with Anti-PD-1 treatment
by: Sheng, W, et al.
Published: (2021)

Stability studies of ALD-52 and its homologue 1P-LSD
by: Zhang, Shu-Hua, et al.
Published: (2023)

Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment
by: Robinson, G, et al.
Published: (2002)

A case report of catatonia and neuroleptic malignant syndrome with multiple treatment modalities: short communication and literature review
by: Chiou, Y, et al.
Published: (2015)

Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjects.
by: Best, N, et al.
Published: (1989)

LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade
by: Sheng, W, et al.
Published: (2018)

Acute kidney injury induced lithium toxicity with concomitant neuroleptic malignant syndrome
by: Lai, Yin Ye, et al.
Published: (2024)

Inositol hexakisphosphate increases the size of platelet aggregates
by: Brehm, M, et al.
Published: (2018)

Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.
by: Costain, D, et al.
Published: (1982)

It never went away : LSD, a sixties drug, attracts young users in the nineties /
by: United States. Department of Justice. Drug Enforcement Administration
Published: ([199)

A tail-based mechanism drives nucleosome demethylation by the LSD2/NPAC multimeric complex
by: Marabelli, C, et al.
Published: (2019)

HALOPERIDOL INCREASES LATENT INHIBITION IN HIGH SCHIZOTYPAL SUBJECTS
by: Williams, J, et al.
Published: (1994)

The effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pineal.
by: Cowen, P, et al.
Published: (1983)

Haloperidol reduces stroop interference and increases negative priming in healthy people
by: Williams, J, et al.
Published: (1996)

Abnormal function of potassium channels in platelets of patients with Alzheimer's disease.
by: de Silva, H, et al.
Published: (1998)

Measurement of specific [3H]-ouabain binding to different types of human leucocytes.
by: Boon, N, et al.
Published: (1984)